LUCID DIAGNOSTICS ($LUCD) posted quarterly earnings results on Monday, March 24th. The company reported earnings of -$0.19 per share, beating estimates of -$0.19 by $0.00. The company also reported revenue of $1,200,000, missing estimates of $1,450,613 by $-250,613.
You can see Quiver Quantitative's $LUCD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LUCID DIAGNOSTICS Hedge Fund Activity
We have seen 18 institutional investors add shares of LUCID DIAGNOSTICS stock to their portfolio, and 20 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SARGENT INVESTMENT GROUP, LLC added 541,500 shares (+inf%) to their portfolio in Q4 2024, for an estimated $443,326
- LUMINUS MANAGEMENT LLC removed 136,195 shares (-11.8%) from their portfolio in Q4 2024, for an estimated $111,502
- CITADEL ADVISORS LLC added 119,887 shares (+inf%) to their portfolio in Q4 2024, for an estimated $98,151
- SUNBELT SECURITIES, INC. added 83,999 shares (+inf%) to their portfolio in Q4 2024, for an estimated $68,769
- LEVIN CAPITAL STRATEGIES, L.P. removed 66,528 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $54,466
- GEODE CAPITAL MANAGEMENT, LLC added 65,964 shares (+30.9%) to their portfolio in Q4 2024, for an estimated $54,004
- GOLDMAN SACHS GROUP INC added 63,575 shares (+inf%) to their portfolio in Q4 2024, for an estimated $52,048
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LUCID DIAGNOSTICS Analyst Ratings
Wall Street analysts have issued reports on $LUCD in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 11/13/2024
- BTIG issued a "Buy" rating on 10/14/2024
To track analyst ratings and price targets for LUCID DIAGNOSTICS, check out Quiver Quantitative's $LUCD forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
